Products for Research Use Only
RegisterLogin

Bemfivastatin hemicalcium

CAT: 0931-T82900-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T82900-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
805241-64-9
Target
Others, HMG-CoA Reductase
Related Pathways
Metabolism, Others
Bioactivity
Bemfivastatin hemicalcium (PPD 10558), an orally active HMG-CoA reductase inhibitor, serves as a lipid-lowering agent. It amplifies liver extract activity and exhibits no-observed adverse effect levels (NOAEL) at dosages of ≥320 mg/kg/d for rat developmental toxicity, ≥12.5 mg/kg/d for rabbit maternal toxicity, and ≥25 mg/kg/d for rabbit developmental toxicity. This compound is utilized in research concerning hypercholesterolemic myalgia in patients intolerant to statins.
Smiles
[O-]C(C[C@H](O)C[C@H](O)CCN1C(C2=CC=C(C=C2)F)=C(C3=CC=CC=C3)C(C(NC4=CC=C(C=C4)CO)=O)=C1C(C)C)=O.[Ca+2]
Molecular Formula
C34H36FN2O6.1/2Ca
Molecular Weight
607.67
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Related Products

CatalogName
T70899-01Vidofludimus hemicalcium
T201854-01Nastorazepide hemicalcium
T12544-01Proglumide hemicalcium
T60496Ketorolac hemicalcium
T87071-01Orforglipron hemicalcium hydrate
T3116-01Atorvastatin hemicalcium salt
T72101-01Atorvastatin hemicalcium trihydrate
T80862-01Vitamin B15 hemicalcium
T10662Calcimycin hemicalcium salt
T4200-01Sacubitril hemicalcium salt

Alternative Products

CatalogName
HY-106281A-01Bemfivastatin (hemicalcium)
GTR19218025-01Bemfivastatin hemicalcium
BA7826-25Bemfivastatin
HY-14575Nastorazepide (hemicalcium)
HY-103354AProglumide (hemicalcium)
HY-B0580C-01Ketorolac (hemicalcium)
GTR19163801-01Atorvastatin hemicalcium
HY-14908AVidofludimus (hemicalcium)
HY-156565ASumonerimod (hemicalcium)
MBS5813441Vidofludimus hemicalcium

Popular Products